BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/23/2022 2:39:01 PM | Browse: 545 | Download: 1177
 |
Received |
|
2022-01-16 12:15 |
|
Peer-Review Started |
|
2022-01-16 12:16 |
|
First Decision by Editorial Office Director |
|
2022-02-08 09:53 |
|
Return for Revision |
|
2022-02-08 09:53 |
|
Revised |
|
2022-02-13 08:17 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-05-23 03:28 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-05-28 07:11 |
|
Articles in Press |
|
2022-05-28 07:11 |
|
Edit the Manuscript by Language Editor |
|
2022-05-19 11:14 |
|
Typeset the Manuscript |
|
2022-05-30 07:25 |
|
Publish the Manuscript Online |
|
2022-06-23 14:39 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Liver dysfunction during COVID-19 pandemic: Contributing role of associated factors in disease progression and severity
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Tarun Sahu, Babita Pande, Manasa PL and Henu Kumar Verma |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Henu Kumar Verma, PhD, Research Scientist, Senior Researcher, Department of Immunopathology, Institute of Lungs Health and Immunity, Ingolstädter Landstrasse 1, Munich 85764, Bavaria, Germany. henu.verma@yahoo.com |
| Key Words |
SARS-CoV-2; COVID-19; Liver function; Hepatic injury; Viral infection |
| Core Tip |
Understanding the hepatic consequences of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, as well as its molecular mechanism, has advanced significantly. Since the start of the pandemic, it appears that there has been thought that pre-existing chronic liver disease may predispose to deprived outcomes when combined with coronavirus disease 19 (COVID-19). Evidence suggests that COVID-19 patients have abnormal liver function more frequently, with more significant elevations in alanine aminotransferase and aspartate aminotransferase in severe COVID-19 patients than those with mild/moderate disease. In this review, we focus on the pathogenesis of SARS-CoV-2 infection in the liver, as well as the use of liver chemistry as a prognostic tool during COVID-19. |
| Publish Date |
2022-06-23 14:39 |
| Citation |
Sahu T, Pande B, PL M, Verma HK. Liver dysfunction during COVID-19 pandemic: Contributing role of associated factors in disease progression and severity. World J Hepatol 2022; 14(6): 1099-1110 |
| URL |
https://www.wjgnet.com/1948-5182/full/v14/i6/1099.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v14.i6.1099 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
